NCT06542705

Brief Summary

The purpose of this study is to assess Anterior Cruciate Ligament (ACL) healing through analyzing clinical, radiographic, functional and patient-reported outcomes following ACL reconstruction with bone-tendon-bone autograft with and without internal bracing.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
34mo left

Started Mar 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Mar 2025Mar 2029

First Submitted

Initial submission to the registry

August 5, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 7, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

March 17, 2025

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2029

Last Updated

March 5, 2026

Status Verified

March 1, 2026

Enrollment Period

4 years

First QC Date

August 5, 2024

Last Update Submit

March 3, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Side to side difference in laxity as measured by the KT-1000 Arthrometer

    The KT-1000 knee arthrometer (KT-1000) is an objective instrument to measure anterior tibial motion relative to the femur for anterior cruciate ligament (ACL) reconstruction. The side-to-side differences comparing the injured and normal extremity allow the determination of a diagnosis of increased anterior-posterior laxity. A side-to-side difference of less than 3mm at 30lb and the manual maximum is considered normal. A side-to-side difference between 3 and 5mm is considered a grey area. A side-to-side difference of more than 5mm is considered diagnostic of an ACL tear.

    Month 12 Post-Operation

  • Side to side difference in laxity as measured by the KT-1000 Arthrometer

    The KT-1000 knee arthrometer (KT-1000) is an objective instrument to measure anterior tibial motion relative to the femur for anterior cruciate ligament (ACL) reconstruction. The side-to-side differences comparing the injured and normal extremity allow the determination of a diagnosis of increased anterior-posterior laxity. A side-to-side difference of less than 3mm at 30lb and the manual maximum is considered normal. A side-to-side difference between 3 and 5mm is considered a grey area. A side-to-side difference of more than 5mm is considered diagnostic of an ACL tear.

    Month 24 Post-Operation

Secondary Outcomes (9)

  • Pivot Shift Grade

    Month 12 Post-Operation

  • Pivot Shift Grade

    Month 24 Post-Operation

  • Change from Baseline in Visual Analogue Scale (VAS) - Pain Score at Month 12 Post-Operation

    Baseline, Month 12 Post-Operation

  • Change from Baseline in Visual Analogue Scale (VAS) - Pain Score at Month 24 Post-Operation

    Baseline, Month 24 Post-Operation

  • Change from Baseline in International Knee Documentation Committee (IKDC) Survey at Month 12 Post-Operation

    Baseline, Month 12 Post-Operation

  • +4 more secondary outcomes

Study Arms (2)

Internal Brace

EXPERIMENTAL

Patients will undergo ACL Reconstruction (ACLR) with an internal brace. Patients will undergo standard perioperative protocol and be followed at typical time points after surgery (2 weeks, 6 weeks, 3 months, 6 months, 12 months). At 12 months postoperative, a follow-up MRI will be obtained to evaluate healing and at 12 months and 24 months follow up KT-1000 testing will be conducted.

Device: Arthrex Internal BraceProcedure: ACL Reconstruction

Standard ACLR

ACTIVE COMPARATOR

Patients will undergo ACLR without an internal brace. Patients will undergo standard perioperative protocol and be followed at typical time points after surgery (2 weeks, 6 weeks, 3 months, 6 months, 12 months). At 12 months postoperative, a follow-up MRI will be obtained to evaluate healing and at 12 months and 24 months follow up KT-1000 testing will be conducted.

Procedure: ACL Reconstruction

Interventions

The Arthrex Internal Brace method for ACL reconstruction consists of suture tape used to reinforce the ACL during surgery. This suture tape is secured in place with bioabsorbable anchors that gradually degrade within the body over time.

Also known as: AR-1593-BC
Internal Brace

All patients will undergo ACL reconstruction (ACLR) with or without an internal brace. ACLR technique will be standardized to standard anteromedial (AM) portal femoral drilling to ensure consistency between surgeons.

Internal BraceStandard ACLR

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients undergoing ACLR with BTB autograft
  • Patients ages 18-35, inclusive
  • Ability to undergo standard rehab protocol and full, painless range of motion at the time of surgery of their operative knee

You may not qualify if:

  • Osteoarthritis defined by Kellgren-Lawrence grade 2 or higher on preoperative weightbearing radiographs
  • Significant chondral injury as defined by grade 3-4 lesion greater than 2cm2
  • History of autoimmune or inflammatory disease
  • Prior ipsilateral knee ligament surgery or multi-ligament knee injury
  • Concomitant Lateral extra-articular tenodesis (LET) procedure
  • History of contralateral ACL surgery
  • Younger than 18 years of age
  • Older than 35 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Langone Health

New York, New York, 10016, United States

RECRUITING

Study Officials

  • Michael J. Alaia, MD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2024

First Posted

August 7, 2024

Study Start

March 17, 2025

Primary Completion (Estimated)

March 1, 2029

Study Completion (Estimated)

March 1, 2029

Last Updated

March 5, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

The de-identified participant data from the final research dataset used in the published manuscript will be shared upon reasonable request beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research provided the investigator who proposes to use the data executes a data use agreement with NYU Langone Health. Requests may be directed to Michael.Alaia@nyulangone.org. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
Access Criteria
The investigator who proposed to use the data will be provided access upon reasonable request. Requests should be directed to Michael.Alaia@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.

Locations